Profil
Maurizio Silvestri is currently the Chief Executive Officer at Archimica SAS and the Chairman & Chief Executive Officer at Mipharm SpA.
He was formerly the Chairman & Chief Executive Officer at Prime European Therapeuticals SpA.
Aktive Positionen von Maurizio Silvestri
| Unternehmen | Position | Beginn |
|---|---|---|
Archimica SAS
 Archimica SAS Pharmaceuticals: GenericHealth Technology Archimica SAS manufactures & distributes pharmaceutical ingredients. Archimica sites have developed unique expertise in the sterilization of bulk active pharmaceutical ingredients (APIs) using high-performance aseptic filtration technology conforming to cGMP standards (ICH Q7A and ICH Q1A compliance). The company was founded in 1987 and is headquartered in Bon-Encontre, France | Vorstandsvorsitzender | 07.07.2011 |
Mipharm SpA
 Mipharm SpA Pharmaceuticals: MajorHealth Technology Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Maurizio Silvestri
| Unternehmen | Position | Ende |
|---|---|---|
Prime European Therapeuticals SpA
 Prime European Therapeuticals SpA Pharmaceuticals: MajorHealth Technology Prime European Therapeuticals SpA manufactures, develops, and markets active pharmaceutical ingredients and intermediates. It also involves in custom synthesis and contract manufacturing as well as projects on fine chemical products. The company was founded in 1984 and is headquartered in Milan, Italy. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Prime European Therapeuticals SpA
Prime European Therapeuticals SpA Pharmaceuticals: MajorHealth Technology Prime European Therapeuticals SpA manufactures, develops, and markets active pharmaceutical ingredients and intermediates. It also involves in custom synthesis and contract manufacturing as well as projects on fine chemical products. The company was founded in 1984 and is headquartered in Milan, Italy. | Health Technology |
Archimica SAS
Archimica SAS Pharmaceuticals: GenericHealth Technology Archimica SAS manufactures & distributes pharmaceutical ingredients. Archimica sites have developed unique expertise in the sterilization of bulk active pharmaceutical ingredients (APIs) using high-performance aseptic filtration technology conforming to cGMP standards (ICH Q7A and ICH Q1A compliance). The company was founded in 1987 and is headquartered in Bon-Encontre, France | Health Technology |
Mipharm SpA
Mipharm SpA Pharmaceuticals: MajorHealth Technology Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy. | Health Technology |
